{"id":"W3036352764","doi":"10.1007/s40257-020-00527-x","title":"Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Open label; Adverse effect; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002967138,0.0001795967,0.001787051,0.0001570887,0.0000498359,0.00002277922,0.0003477527,0.00008331755,0.00001312736],"category_scores_gemma":[0.00155411,0.0001441051,0.00005664761,0.0003743103,0.0002689862,0.0002032817,0.0001330725,0.0003248669,0.000002961322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001667803,"about_ca_system_score_gemma":0.0004549753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004648419,"about_ca_topic_score_gemma":0.0001161179,"domain_scores_codex":[0.9971303,0.0004884314,0.001552161,0.0003353577,0.0001917733,0.0003020149],"domain_scores_gemma":[0.9971632,0.0009267253,0.000598284,0.0002344379,0.0003768022,0.0007004901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07896884,0.004825442,0.8582894,0.00029641,0.0004611126,0.002344515,0.008549792,0.0001956061,0.00001088071,0.0001159028,0.00314544,0.04279671],"study_design_scores_gemma":[0.07761538,0.03268938,0.863245,0.0004208488,0.0003642574,0.002145765,0.01997476,0.001567263,0.00004668849,0.00008513629,0.001502932,0.0003426303],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863247,0.00007131584,0.0006272892,0.01137784,0.00006563672,0.001468271,0.0000116955,0.00001138446,0.00004182924],"genre_scores_gemma":[0.9898097,0.000038046,0.003348092,0.006699657,0.00003923841,0.00002361818,0.000005125006,0.000024179,0.00001233065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04245408,"threshold_uncertainty_score":0.5876437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04485148388255634,"score_gpt":0.3839348872599036,"score_spread":0.3390834033773473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}